VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SER
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SERSerina Therapeutics, Inc.
$2.17$24M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSERQuarterly Financials

Serina Therapeutics, Inc. (SER) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Serina Therapeutics, Inc. (SER) quarterly income statement — complete revenue, gross profit & net income history

SER Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue000130K0-14K14K05K3.09M29K7K30K8K9K12K5K2K24K37K
Revenue Growth %-100%-100%--100%-100.45%-51.72%-100%-83.33%38487.5%222.22%-41.67%500%300%-62.5%-67.57%-91.07%-99.6%-94.47%-91.06%
Cost of Goods Sold18K0016K000025K6K53K18K13K34K38K39K34K34K34K46K
COGS % of Revenue---12.31%----500%0.19%182.76%257.14%43.33%425%422.22%325%680%1700%141.67%124.32%
Gross Profit-18K00114K0-14K14K0-20K3.08M-24K-11K17K-26K-29K-27K-29K-32K-10K-9K
Gross Margin %---87.69%-100%100%--400%99.81%-82.76%-157.14%56.67%-325%-322.22%-225%-580%-1600%-41.67%-24.32%
Gross Profit Growth %-100%-100%-100%-100.45%158.33%100%-217.65%11950%17.24%59.26%158.62%18.75%-190%-200%-245%70.91%-171.43%-190%
Operating Expenses6.26M6.21M6.39M5.68M5.86M5.54M5.33M3.87M2.3M2.84M1.44M934K979K1.76M1.52M1.56M2.02M1.86M1.66M2.2M
OpEx % of Revenue---4368.46%--39535.71%38042.86%-46020%92%4962.07%13342.86%3263.33%21950%16900%13033.33%40460%93000%6933.33%5935.14%
Selling, General & Admin3.08M2.81M2.74M2.54M2.91M3.17M2.91M2.32M1.22M1.93M889K473K593K1.58M1.39M1.34M1.66M1.52M1.42M1.75M
SG&A % of Revenue---1956.15%--22642.86%20792.86%-24400%62.62%3065.52%6757.14%1976.67%19762.5%15466.67%11150%33200%75850%5920.83%4724.32%
Research & Development3.2M3.4M3.65M3.15M2.95M2.37M2.42M1.59M1.11M907K550K479K399K175K129K226K363K343K243K448K
R&D % of Revenue---2424.62%--16892.86%17250%-22120%29.38%1896.55%6842.86%1330%2187.5%1433.33%1883.33%7260%17150%1012.5%1210.81%
Other Operating Expenses000-16K000-51K-25K00-18K-13K0000000
Operating Income-6.28M-6.21M-6.39M-5.57M-5.86M-5.55M-5.31M-3.87M-2.32M241K-1.46M-945K-962K-1.78M-1.55M-1.59M-2.05M-1.89M-1.67M-2.21M
Operating Margin %----4280.77%-39635.71%-37942.86%--46420%7.81%-5044.83%-13500%-3206.67%-22275%-17222.22%-13258.33%-41040%-94600%-6975%-5959.46%
Operating Income Growth %-7.2%-11.86%-20.33%-43.95%-152.39%-2402.49%-263.09%-309.1%-141.27%113.52%5.61%40.6%53.12%5.81%7.41%27.85%10.51%22.68%30.37%16%
EBITDA-6.26M-6.18M-6.38M-5.55M-5.84M-5.49M-5.26M-3.81M-2.3M247K-1.41M-928K-949K-1.75M-1.52M-1.56M-2.02M-1.86M-1.64M-2.17M
EBITDA Margin %----4268.46%-39235.71%-37542.86%--45920%8%-4862.07%-13257.14%-3163.33%-21862.5%-16855.56%-12983.33%-40380%-92950%-6841.67%-5870.27%
EBITDA Growth %-7.21%-12.56%-21.31%-45.68%-154.4%-2323.89%-272.77%-310.45%-141.94%114.12%7.05%40.44%53%5.92%7.61%28.27%10.66%0.59%19.27%3.77%
D&A (Non-Cash Add-back)18K24K16K16K17K56K56K57K25K6K53K17K13K33K33K33K33K33K32K33K
EBIT-6.28M-3.12M-4.59M-6.45M-4.82M-2.73M1.4M5.42M-14.83M1.23M1.85M916K1.74M-1.78M-1.51M-1.75M-1.59M-1.86M-1.67M-2.2M
Net Interest Income189K-198K-6K-9K0-17K-16K-242K-99K-176K-100K-108K-86K-978K-923K-863K-1.11M-295K-285K-274K
Interest Income00000000000000000000
Interest Expense-189K198K6K9K017K16K242K99K176K100K108K86K978K923K863K1.11M295K285K274K
Other Income/Expense-611K2.89M1.8M-897K1.04M2.8M6.7M9.04M-12.69M810K3.21M1.75M2.62M-979K-886K-1.03M-655K-267K-281K-270K
Pretax Income-6.89M-3.32M-4.59M-6.46M-4.82M-2.75M1.38M5.18M-15.02M1.05M1.75M808K1.66M-2.76M-2.44M-2.62M-2.71M-2.16M-1.96M-2.48M
Pretax Margin %----4970.77%-19657.14%9878.57%--300300%34.05%6041.38%11542.86%5526.67%-34512.5%-27066.67%-21816.67%-54140%-107950%-8145.83%-6689.19%
Income Tax7K18K000000000000000000
Effective Tax Rate %-0.1%-0.54%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-6.9M-3.34M-4.58M-6.45M-4.81M-2.74M1.41M5.2M-15.02M1.05M1.75M808K1.66M-2.7M-2.44M-2.62M-2.71M-2.16M-1.96M-2.47M
Net Margin %----4960%-19571.43%10071.43%--300300%34.05%6041.38%11542.86%5526.67%-33787.5%-27055.56%-21816.67%-54120%-107900%-8145.83%-6686.49%
Net Income Growth %-43.32%-21.75%-425.18%-223.9%67.95%-360.7%-19.52%544.06%-1005.61%138.88%171.95%130.86%161.27%-25.25%-24.55%-5.82%-29.6%11.77%23.12%8%
Net Income (Continuing)-6.9M-3.34M-4.59M-6.46M-4.82M-2.75M1.38M5.18M-15.02M1.05M1.75M808K1.66M-2.76M-2.44M-2.62M-2.71M-2.16M-1.96M-2.48M
Discontinued Operations00000000000000000000
Minority Interest00-166K-156K-142K-133K-54K-30K00-109K-121K-111K-103K-45K-44K-44K-43K-42K-42K
EPS (Diluted)-0.58-0.31-0.44-0.64-0.49-0.250.130.51-5.380.440.23-0.240.20-2.51-2.26-2.43-2.51-2.00-1.81-2.29
EPS Growth %-18.37%-24%-438.46%-225.49%90.89%-156.82%-43.48%312.5%-2790%117.53%110.18%90.12%107.97%-25.5%-24.86%-6.11%-28.72%12.28%23.63%8.76%
EPS (Basic)-0.58-0.31-0.44-0.64-0.49-0.310.160.61-5.380.440.800.370.77-2.51-2.26-2.43-2.51-2.00-1.81-2.29
Diluted Shares Outstanding12.05M10.19M10.34M10M9.76M10.75M10.75M10.16M2.79M1.08M7.58M1.08M1.08M1.08M1.08M1.08M1.08M1.08M1.08M1.08M
Basic Shares Outstanding12.05M10.19M10.34M10M9.76M8.85M8.85M8.51M2.79M1.08M2.19M1.08M1.08M1.08M1.08M1.08M1.08M1.08M1.08M1.08M
Dividend Payout Ratio--------------------